Ambulatory Surgical Centers Market by Service Category (Diagnostic, Therapeutic), Ownership (Corporate Owned, Hospital Owned, Physician Owned), Facility Type, Operating Room Capacity, Payer Type, Procedure Specialty - Global Forecast 2025-2032
Description
The Ambulatory Surgical Centers Market was valued at USD 84.90 billion in 2024 and is projected to grow to USD 92.44 billion in 2025, with a CAGR of 9.57%, reaching USD 176.40 billion by 2032.
A concise orientation to the converging clinical, financial, and operational forces reshaping ambulatory surgical centers and their strategic significance
Ambulatory surgical centers are at the epicenter of a fundamental shift in the delivery of procedural care, blending clinical efficiency with patient-centric convenience. Growth in outpatient procedures, advances in minimally invasive techniques, and evolving reimbursement protocols have collectively elevated the strategic importance of these facilities for providers, payers, and device manufacturers alike. As a result, industry stakeholders must reassess operational models, capital deployment, and partnerships to maintain competitive positioning in a landscape defined by both rapid innovation and cost pressures.
Against this backdrop, facility operators are navigating a complex intersection of clinical quality imperatives and financial sustainability targets. New modalities of care require investment in specialized equipment, staff training, and digital infrastructure, while payers and regulators continue to refine coverage policies and quality measures. Therefore, leaders who integrate clinical pathways with strategic procurement and payer engagement will be better positioned to capture the efficiency and experience gains that ambulatory settings promise. In short, the introduction sets the stage for a holistic analysis of structural change drivers shaping the sector’s near- to mid-term trajectory.
An in-depth analysis of how technological advances, payer reforms, and shifting ownership models are driving structural transformation across outpatient procedural care
The ambulatory surgical center landscape is undergoing transformative shifts driven by technological innovation, payer realignment, and evolving care preferences that favor lower-cost, higher-convenience settings. Minimally invasive surgical techniques and advances in local and regional anesthesia have expanded the clinical scope of outpatient centers, enabling more complex procedures to migrate from inpatient settings. Concurrently, digital tools such as telehealth pre-op consultations, electronic care pathways, and perioperative remote monitoring are optimizing throughput and enhancing patient experience, thereby reinforcing outpatient placement as a preferred care setting for appropriate case mixes.
Moreover, commercial and government payers are increasingly steering care toward value-based arrangements that reward efficiency and outcomes, prompting closer collaboration between centers, physician groups, and health plans. As providers adapt, ownership models are also evolving, with capital partners and integrated health systems exploring novel arrangements to capture outpatient procedure volumes. Supply chain modernization and the adoption of reusable and single-use device innovations are further altering procurement strategies, while workforce dynamics-including staffing shortages and the need for cross-trained clinicians-are prompting investment in process redesign. Taken together, these shifts signal a sector transitioning from opportunistic growth to strategic consolidation and capability-driven competition.
A pragmatic examination of how US tariff developments are reshaping procurement, supplier strategies, and contract dynamics for ambulatory surgical centers
Recent tariff policy developments in the United States have introduced additional complexity into capital equipment sourcing and consumables procurement for ambulatory surgical centers. Import duties and related trade measures can raise landed costs for high-value devices, single-use disposables, and diagnostic equipment sourced internationally, thereby exerting pressure on procurement budgets and contracting models. In response, many organizations are reassessing supplier footprints, seeking greater visibility into total cost of ownership, and accelerating qualification of alternative vendors to mitigate supply-chain exposure.
Consequently, procurement leaders are increasingly focused on strategies that limit tariff risk, including diversification of supplier bases, reshoring or nearshoring of key supply lines, and redesign of product specifications to change tariff classifications where permissible. These adjustments often require longer lead times and closer collaboration with clinical stakeholders to ensure substitutions maintain quality and regulatory compliance. In parallel, some centers are renegotiating payer contracts and facility fee structures to reflect higher input costs, while others absorb incremental expenses to preserve competitive pricing for patients. Overall, tariff-related pressures are prompting a strategic reorientation in sourcing, capital planning, and contract management across the sector.
A comprehensive dissection of how service mix, ownership form, facility specialization, OR capacity, payer composition, and procedural specialties dictate strategic priorities
Segment-level insights reveal how differences in service orientation, ownership structure, facility specialization, operating capacity, payer mix, and procedural focus materially influence strategic priorities and operational trade-offs within ambulatory surgical centers. When centers concentrate on diagnostic services versus therapeutic procedures, investment profiles and staff competencies diverge, guiding choices around equipment procurement and patient flow design. Ownership models further differentiate strategy: corporate owned entities often prioritize scalable standards and technology platforms, hospital owned centers emphasize clinical integration and downstream referrals, while physician owned facilities typically align investments closely with clinician workflows and specialty-specific needs.
Facility type also affects strategic focus; multi-specialty centers must balance cross-disciplinary scheduling and shared resource allocation, whereas single-specialty sites can optimize layout and supply chains for concentrated procedural volumes. Operating room capacity creates another axis of differentiation, with centers operating one to two ORs concentrating on efficiency and turnover optimization, three to four ORs requiring flexible staffing and scheduling strategies, and facilities with five or more ORs investing in enterprise-level systems and throughput analytics. Payer type is a critical determinant of revenue cycle complexity and patient access policies; centers serving a higher share of Medicaid or Medicare patients face unique reimbursement constraints compared with those relying on private insurance or self-pay streams. Finally, procedure specialty informs clinical staffing, capital equipment, and marketing strategies; specialties ranging from dental surgery and dermatology to orthopedics and urology each carry distinct clinical protocols, device needs, and referral dynamics. Taken together, these segmentation dimensions enable more granular strategic planning and targeted investment to optimize clinical outcomes and financial performance.
A nuanced exploration of how regional regulatory, payer, and workforce dynamics across major world regions shape strategic options for ambulatory surgical centers
Regional dynamics exert distinct influences on regulatory frameworks, payer behavior, workforce availability, and capital flows relevant to ambulatory surgical centers. In the Americas, market developments are shaped by diverse state-level regulations, a mature private payer environment, and ongoing initiatives to transition suitable procedures to outpatient settings; this region demonstrates robust clinical innovation adoption and active private investment seeking operational scale. By contrast, Europe, Middle East & Africa present a heterogeneous regulatory and payer tapestry, with some markets emphasizing public system integration and quality oversight while others are characterized by private sector growth and nascent outpatient penetration; cross-border procurement and staffing mobility are notable considerations in these markets.
In the Asia-Pacific region, rapid urbanization, expanding private healthcare capacity, and rising procedural demand are driving growth in ambulatory facilities, but adoption rates vary markedly by country due to regulatory frameworks, reimbursement models, and local clinical practice norms. Across all regions, supply-chain resilience and local manufacturing capabilities remain pivotal, and regional reimbursement trends continue to influence capital investment timing. Therefore, stakeholders evaluating regional expansion or partnerships must weigh regulatory complexity, payer receptivity to outpatient procedures, and workforce supply against strategic ambitions for scale and specialty mix.
An incisive summary of industry competitive moves highlighting vertical integration, technology-driven differentiation, and collaboration patterns among operators and suppliers
Competitive dynamics among companies operating within and adjacent to the ambulatory surgical center ecosystem are accelerating around vertical integration, digital enablement, and service-line specialization. Operators and investors are concentrating on consolidating platform capabilities, acquiring complementary specialty practices, and integrating advanced revenue-cycle and scheduling systems to improve margins and utilization. Device manufacturers and disposable suppliers are responding with product portfolios tailored to ambulatory workflows, emphasizing ease of use, sterilization efficiency, and cost containment to meet the unique needs of outpatient environments.
Meanwhile, software and digital health vendors are forging deeper partnerships with operators to provide end-to-end perioperative solutions that span patient engagement, preoperative optimization, surgical scheduling, and postoperative remote monitoring. Strategic alliances between clinical groups and capital partners are enabling faster site development and expansion of specialty services. In aggregate, the industry is witnessing a convergence of clinical, operational, and technological capabilities that favors organizations capable of delivering integrated, scalable outpatient solutions while maintaining rigorous quality and regulatory compliance.
Action-oriented strategic imperatives for leaders to reinforce clinical quality, operational efficiency, supply-chain resilience, and payer engagement in ambulatory care
Industry leaders should pursue a proactive agenda that aligns clinical quality, operational efficiency, and commercial resilience to capture the ambulatory care opportunity. First, centers should prioritize investments in perioperative digital workflows and telehealth-enabled pathways that reduce no-shows, streamline pre-op clearance, and shorten patient throughput times. These investments should be complemented by focused workforce strategies that emphasize cross-training, flexible scheduling, and retention incentives to mitigate staffing volatility.
Second, procurement and supply-chain leaders must elevate tariff and supplier-risk management to board-level priorities, diversifying sourcing, negotiating longer-term contracts with price-protection clauses, and evaluating nearshore manufacturing partners to improve cost predictability. Third, clinical and commercial leaders should collaborate to design payer engagement strategies that demonstrate value through outcome metrics and cost comparisons, thereby strengthening position in value-based arrangements. Finally, for organizations contemplating expansion or consolidation, rigorous due diligence on specialty alignment, licensing, and local reimbursement landscapes is essential to ensure accretive growth. Executed together, these actions will help leaders reduce operational friction, protect margins, and accelerate patient-centered growth.
A rigorous mixed-methods research framework combining stakeholder interviews, documentary analysis, triangulation, and segmentation-based validation to ensure actionable insights
The research approach integrates qualitative and quantitative inquiry to produce robust, validated insights suitable for strategic decision-making. Primary research included structured interviews with a cross-section of stakeholders-facility executives, physician leaders, supply-chain managers, payer representatives, and clinical staff-to capture first-hand perspectives on operational challenges, technology adoption, and contracting dynamics. Secondary research encompassed review of regulatory guidance, clinical literature, public filings, and industry white papers to contextualize primary findings and identify emergent trends.
Findings were triangulated through iterative validation, cross-referencing interview insights with documented policy changes and reported industry initiatives. Segmentation analysis was applied to isolate trends by service category, ownership type, facility specialization, OR capacity configurations, payer composition, and procedure specialty, thereby ensuring that recommendations are actionable at both portfolio and facility levels. Finally, analytic limitations and potential biases were explicitly documented, and sensitivity checks were performed to ensure conclusions remain robust across plausible operational scenarios.
A forward-looking synthesis that underscores the strategic balance between clinical capability expansion, operational rigor, and commercial adaptability in ambulatory care
In conclusion, ambulatory surgical centers occupy a pivotal role in the evolution of procedural care delivery, propelled by clinical advances, payer incentives, and patient preferences for convenience. The sector faces a dual mandate to expand clinical capabilities while containing costs and safeguarding quality, and success hinges on leaders’ ability to align investments in technology, workforce, and supply-chain strategies with evolving reimbursement and regulatory realities. Practical initiatives that combine digital perioperative pathways, supplier diversification, and targeted payer engagement will be most effective in driving sustainable operational improvement.
As the landscape continues to mature, the organizations that adopt an integrative approach-aligning clinical excellence with scalable operational systems and proactive commercial strategies-will be best positioned to capture long-term value. Continued vigilance around regulatory changes, tariff impacts, and regional differences will remain essential, as will disciplined execution of growth initiatives anchored in empirical performance metrics. Ultimately, the path to durable success in ambulatory care requires both tactical responsiveness and strategic foresight.
Please Note: PDF & Excel + Online Access - 1 Year
A concise orientation to the converging clinical, financial, and operational forces reshaping ambulatory surgical centers and their strategic significance
Ambulatory surgical centers are at the epicenter of a fundamental shift in the delivery of procedural care, blending clinical efficiency with patient-centric convenience. Growth in outpatient procedures, advances in minimally invasive techniques, and evolving reimbursement protocols have collectively elevated the strategic importance of these facilities for providers, payers, and device manufacturers alike. As a result, industry stakeholders must reassess operational models, capital deployment, and partnerships to maintain competitive positioning in a landscape defined by both rapid innovation and cost pressures.
Against this backdrop, facility operators are navigating a complex intersection of clinical quality imperatives and financial sustainability targets. New modalities of care require investment in specialized equipment, staff training, and digital infrastructure, while payers and regulators continue to refine coverage policies and quality measures. Therefore, leaders who integrate clinical pathways with strategic procurement and payer engagement will be better positioned to capture the efficiency and experience gains that ambulatory settings promise. In short, the introduction sets the stage for a holistic analysis of structural change drivers shaping the sector’s near- to mid-term trajectory.
An in-depth analysis of how technological advances, payer reforms, and shifting ownership models are driving structural transformation across outpatient procedural care
The ambulatory surgical center landscape is undergoing transformative shifts driven by technological innovation, payer realignment, and evolving care preferences that favor lower-cost, higher-convenience settings. Minimally invasive surgical techniques and advances in local and regional anesthesia have expanded the clinical scope of outpatient centers, enabling more complex procedures to migrate from inpatient settings. Concurrently, digital tools such as telehealth pre-op consultations, electronic care pathways, and perioperative remote monitoring are optimizing throughput and enhancing patient experience, thereby reinforcing outpatient placement as a preferred care setting for appropriate case mixes.
Moreover, commercial and government payers are increasingly steering care toward value-based arrangements that reward efficiency and outcomes, prompting closer collaboration between centers, physician groups, and health plans. As providers adapt, ownership models are also evolving, with capital partners and integrated health systems exploring novel arrangements to capture outpatient procedure volumes. Supply chain modernization and the adoption of reusable and single-use device innovations are further altering procurement strategies, while workforce dynamics-including staffing shortages and the need for cross-trained clinicians-are prompting investment in process redesign. Taken together, these shifts signal a sector transitioning from opportunistic growth to strategic consolidation and capability-driven competition.
A pragmatic examination of how US tariff developments are reshaping procurement, supplier strategies, and contract dynamics for ambulatory surgical centers
Recent tariff policy developments in the United States have introduced additional complexity into capital equipment sourcing and consumables procurement for ambulatory surgical centers. Import duties and related trade measures can raise landed costs for high-value devices, single-use disposables, and diagnostic equipment sourced internationally, thereby exerting pressure on procurement budgets and contracting models. In response, many organizations are reassessing supplier footprints, seeking greater visibility into total cost of ownership, and accelerating qualification of alternative vendors to mitigate supply-chain exposure.
Consequently, procurement leaders are increasingly focused on strategies that limit tariff risk, including diversification of supplier bases, reshoring or nearshoring of key supply lines, and redesign of product specifications to change tariff classifications where permissible. These adjustments often require longer lead times and closer collaboration with clinical stakeholders to ensure substitutions maintain quality and regulatory compliance. In parallel, some centers are renegotiating payer contracts and facility fee structures to reflect higher input costs, while others absorb incremental expenses to preserve competitive pricing for patients. Overall, tariff-related pressures are prompting a strategic reorientation in sourcing, capital planning, and contract management across the sector.
A comprehensive dissection of how service mix, ownership form, facility specialization, OR capacity, payer composition, and procedural specialties dictate strategic priorities
Segment-level insights reveal how differences in service orientation, ownership structure, facility specialization, operating capacity, payer mix, and procedural focus materially influence strategic priorities and operational trade-offs within ambulatory surgical centers. When centers concentrate on diagnostic services versus therapeutic procedures, investment profiles and staff competencies diverge, guiding choices around equipment procurement and patient flow design. Ownership models further differentiate strategy: corporate owned entities often prioritize scalable standards and technology platforms, hospital owned centers emphasize clinical integration and downstream referrals, while physician owned facilities typically align investments closely with clinician workflows and specialty-specific needs.
Facility type also affects strategic focus; multi-specialty centers must balance cross-disciplinary scheduling and shared resource allocation, whereas single-specialty sites can optimize layout and supply chains for concentrated procedural volumes. Operating room capacity creates another axis of differentiation, with centers operating one to two ORs concentrating on efficiency and turnover optimization, three to four ORs requiring flexible staffing and scheduling strategies, and facilities with five or more ORs investing in enterprise-level systems and throughput analytics. Payer type is a critical determinant of revenue cycle complexity and patient access policies; centers serving a higher share of Medicaid or Medicare patients face unique reimbursement constraints compared with those relying on private insurance or self-pay streams. Finally, procedure specialty informs clinical staffing, capital equipment, and marketing strategies; specialties ranging from dental surgery and dermatology to orthopedics and urology each carry distinct clinical protocols, device needs, and referral dynamics. Taken together, these segmentation dimensions enable more granular strategic planning and targeted investment to optimize clinical outcomes and financial performance.
A nuanced exploration of how regional regulatory, payer, and workforce dynamics across major world regions shape strategic options for ambulatory surgical centers
Regional dynamics exert distinct influences on regulatory frameworks, payer behavior, workforce availability, and capital flows relevant to ambulatory surgical centers. In the Americas, market developments are shaped by diverse state-level regulations, a mature private payer environment, and ongoing initiatives to transition suitable procedures to outpatient settings; this region demonstrates robust clinical innovation adoption and active private investment seeking operational scale. By contrast, Europe, Middle East & Africa present a heterogeneous regulatory and payer tapestry, with some markets emphasizing public system integration and quality oversight while others are characterized by private sector growth and nascent outpatient penetration; cross-border procurement and staffing mobility are notable considerations in these markets.
In the Asia-Pacific region, rapid urbanization, expanding private healthcare capacity, and rising procedural demand are driving growth in ambulatory facilities, but adoption rates vary markedly by country due to regulatory frameworks, reimbursement models, and local clinical practice norms. Across all regions, supply-chain resilience and local manufacturing capabilities remain pivotal, and regional reimbursement trends continue to influence capital investment timing. Therefore, stakeholders evaluating regional expansion or partnerships must weigh regulatory complexity, payer receptivity to outpatient procedures, and workforce supply against strategic ambitions for scale and specialty mix.
An incisive summary of industry competitive moves highlighting vertical integration, technology-driven differentiation, and collaboration patterns among operators and suppliers
Competitive dynamics among companies operating within and adjacent to the ambulatory surgical center ecosystem are accelerating around vertical integration, digital enablement, and service-line specialization. Operators and investors are concentrating on consolidating platform capabilities, acquiring complementary specialty practices, and integrating advanced revenue-cycle and scheduling systems to improve margins and utilization. Device manufacturers and disposable suppliers are responding with product portfolios tailored to ambulatory workflows, emphasizing ease of use, sterilization efficiency, and cost containment to meet the unique needs of outpatient environments.
Meanwhile, software and digital health vendors are forging deeper partnerships with operators to provide end-to-end perioperative solutions that span patient engagement, preoperative optimization, surgical scheduling, and postoperative remote monitoring. Strategic alliances between clinical groups and capital partners are enabling faster site development and expansion of specialty services. In aggregate, the industry is witnessing a convergence of clinical, operational, and technological capabilities that favors organizations capable of delivering integrated, scalable outpatient solutions while maintaining rigorous quality and regulatory compliance.
Action-oriented strategic imperatives for leaders to reinforce clinical quality, operational efficiency, supply-chain resilience, and payer engagement in ambulatory care
Industry leaders should pursue a proactive agenda that aligns clinical quality, operational efficiency, and commercial resilience to capture the ambulatory care opportunity. First, centers should prioritize investments in perioperative digital workflows and telehealth-enabled pathways that reduce no-shows, streamline pre-op clearance, and shorten patient throughput times. These investments should be complemented by focused workforce strategies that emphasize cross-training, flexible scheduling, and retention incentives to mitigate staffing volatility.
Second, procurement and supply-chain leaders must elevate tariff and supplier-risk management to board-level priorities, diversifying sourcing, negotiating longer-term contracts with price-protection clauses, and evaluating nearshore manufacturing partners to improve cost predictability. Third, clinical and commercial leaders should collaborate to design payer engagement strategies that demonstrate value through outcome metrics and cost comparisons, thereby strengthening position in value-based arrangements. Finally, for organizations contemplating expansion or consolidation, rigorous due diligence on specialty alignment, licensing, and local reimbursement landscapes is essential to ensure accretive growth. Executed together, these actions will help leaders reduce operational friction, protect margins, and accelerate patient-centered growth.
A rigorous mixed-methods research framework combining stakeholder interviews, documentary analysis, triangulation, and segmentation-based validation to ensure actionable insights
The research approach integrates qualitative and quantitative inquiry to produce robust, validated insights suitable for strategic decision-making. Primary research included structured interviews with a cross-section of stakeholders-facility executives, physician leaders, supply-chain managers, payer representatives, and clinical staff-to capture first-hand perspectives on operational challenges, technology adoption, and contracting dynamics. Secondary research encompassed review of regulatory guidance, clinical literature, public filings, and industry white papers to contextualize primary findings and identify emergent trends.
Findings were triangulated through iterative validation, cross-referencing interview insights with documented policy changes and reported industry initiatives. Segmentation analysis was applied to isolate trends by service category, ownership type, facility specialization, OR capacity configurations, payer composition, and procedure specialty, thereby ensuring that recommendations are actionable at both portfolio and facility levels. Finally, analytic limitations and potential biases were explicitly documented, and sensitivity checks were performed to ensure conclusions remain robust across plausible operational scenarios.
A forward-looking synthesis that underscores the strategic balance between clinical capability expansion, operational rigor, and commercial adaptability in ambulatory care
In conclusion, ambulatory surgical centers occupy a pivotal role in the evolution of procedural care delivery, propelled by clinical advances, payer incentives, and patient preferences for convenience. The sector faces a dual mandate to expand clinical capabilities while containing costs and safeguarding quality, and success hinges on leaders’ ability to align investments in technology, workforce, and supply-chain strategies with evolving reimbursement and regulatory realities. Practical initiatives that combine digital perioperative pathways, supplier diversification, and targeted payer engagement will be most effective in driving sustainable operational improvement.
As the landscape continues to mature, the organizations that adopt an integrative approach-aligning clinical excellence with scalable operational systems and proactive commercial strategies-will be best positioned to capture long-term value. Continued vigilance around regulatory changes, tariff impacts, and regional differences will remain essential, as will disciplined execution of growth initiatives anchored in empirical performance metrics. Ultimately, the path to durable success in ambulatory care requires both tactical responsiveness and strategic foresight.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
193 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of telemedicine preoperative consultations to optimize surgical scheduling and patient outcomes
- 5.2. Adoption of value-based reimbursement models by ambulatory surgical centers to improve cost-efficiency and quality metrics
- 5.3. Rapid expansion of same-day orthopedic and spine procedures driven by advanced minimally invasive surgical technologies
- 5.4. Incorporation of robotic-assisted surgical platforms in outpatient settings to enhance precision and reduce recovery times
- 5.5. Strategic consolidation through private equity acquisitions and partnerships to diversify service offerings and geographic reach
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Ambulatory Surgical Centers Market, by Service Category
- 8.1. Diagnostic
- 8.2. Therapeutic
- 9. Ambulatory Surgical Centers Market, by Ownership
- 9.1. Corporate Owned
- 9.2. Hospital Owned
- 9.3. Physician Owned
- 10. Ambulatory Surgical Centers Market, by Facility Type
- 10.1. Multi-Specialty
- 10.2. Single Specialty
- 11. Ambulatory Surgical Centers Market, by Operating Room Capacity
- 11.1. Five Or More
- 11.2. One To Two
- 11.3. Three To Four
- 12. Ambulatory Surgical Centers Market, by Payer Type
- 12.1. Medicaid
- 12.2. Medicare
- 12.3. Private Insurance
- 12.4. Self-Pay
- 13. Ambulatory Surgical Centers Market, by Procedure Specialty
- 13.1. Dental Surgery
- 13.2. Dermatology
- 13.3. Ent
- 13.4. Gastroenterology
- 13.5. Gynecology
- 13.6. Ophthalmology
- 13.7. Orthopedics
- 13.8. Pain Management
- 13.9. Plastic Surgery
- 13.10. Urology
- 14. Ambulatory Surgical Centers Market, by Region
- 14.1. Americas
- 14.1.1. North America
- 14.1.2. Latin America
- 14.2. Europe, Middle East & Africa
- 14.2.1. Europe
- 14.2.2. Middle East
- 14.2.3. Africa
- 14.3. Asia-Pacific
- 15. Ambulatory Surgical Centers Market, by Group
- 15.1. ASEAN
- 15.2. GCC
- 15.3. European Union
- 15.4. BRICS
- 15.5. G7
- 15.6. NATO
- 16. Ambulatory Surgical Centers Market, by Country
- 16.1. United States
- 16.2. Canada
- 16.3. Mexico
- 16.4. Brazil
- 16.5. United Kingdom
- 16.6. Germany
- 16.7. France
- 16.8. Russia
- 16.9. Italy
- 16.10. Spain
- 16.11. China
- 16.12. India
- 16.13. Japan
- 16.14. Australia
- 16.15. South Korea
- 17. Competitive Landscape
- 17.1. Market Share Analysis, 2024
- 17.2. FPNV Positioning Matrix, 2024
- 17.3. Competitive Analysis
- 17.3.1. United Surgical Partners International, Inc.
- 17.3.2. SCA Health
- 17.3.3. AmSurg Corporation
- 17.3.4. Surgery Partners, Inc.
- 17.3.5. HCA Healthcare, Inc.
- 17.3.6. Tenet Healthcare Corporation
- 17.3.7. Aspen Healthcare Limited
- 17.3.8. Nueterra Healthcare, LLC
- 17.3.9. SurgCenter Development, LLC
- 17.3.10. Envision Healthcare Holdings, Inc.
- 17.3.11. Medical Facilities Corporation
- 17.3.12. Symbion, LLC
- 17.3.13. IntegraMed America, Inc.
- 17.3.14. OakBend Medical Center Ambulatory Surgery Centers, Inc.
- 17.3.15. Ascension Surgery Centers, LLC
- 17.3.16. TeamHealth Holdings, Inc.
- 17.3.17. AdventHealth Surgery Centers, LLC
- 17.3.18. Northside Surgery Center Holdings, LLC
- 17.3.19. Premier Surgical Partnership, LLC
- 17.3.20. Alliance HealthCare Services, Inc.
- 17.3.21. Coast Surgical Partners, LLC
- 17.3.22. Corewell Health Ambulatory Surgery Centers, Inc.
- 17.3.23. U.S. Specialty Surgical Partners, LLC
- 17.3.24. Surgical Alliance Holdings, Inc.
- 17.3.25. Global Surgical Partners, LLC
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
